Efficacy and Safety of Natalizumab in Crohn’s Disease Patients Treated at 5 Academic Hospitals

Juillerat, P; Wasan, SK; Fowler, SA; Yajnik, V; Korzenik, JR; Pabby, VK; Friedman, S; Coukos, JA; Barto, AE; Pellish, R; and Farraye, FA (2012). Efficacy and Safety of Natalizumab in Crohn’s Disease Patients Treated at 5 Academic Hospitals. Journal of Crohn's & Colitis, 6(Supplement 1), p. 128. Amsterdam: Elsevier

Full text not available from this repository. (Request a copy)

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Visceral Surgery and Medicine > Gastroenterology

UniBE Contributor:

Juillerat, Pascal

ISSN:

1873-9946

Publisher:

Elsevier

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:40

Last Modified:

27 Jun 2014 11:36

URI:

https://boris.unibe.ch/id/eprint/16193 (FactScience: 223781)

Actions (login required)

Edit item Edit item
Provide Feedback